HermineBrunnerMDMSC MBA

Pediatric Rheumatology • Cincinnati, OH

Director, Division of Rheumatology Endowed Chair and Professor of Pediatrics, University of Cincinnato

Join to view full profile

Dr. Brunner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brunner's full profile

Already have an account?

Office
3333 Burnet Ave
Cincinnati, OH 45229
Phone+1 513-636-4676

Fax+1 513-636-5568

Summary

Dr. Hermine Brunner is a pediatric rheumatologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. She received her medical degree from Ludwig Maximilian University of Munich Faculty of Medicine and has been in practice 29 years. She also speaks multiple languages, including German. She is experienced in pediatric rheumatology, clinical research, and drug development.

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Rheumatology, 1999 - 2001
University of ChicagoResidency, Pediatrics, 1994 - 1997
Ludwig Maximilian University of Munich Faculty of MedicineClass of 1989
Ludwig Maximilian University of Munich Faculty of MedicineClass of 1987

Certifications & Licensure

KY State Medical License 2021 - 2025
OH State Medical License 2000 - 2025
PA State Medical License 2001 - 2002
IL State Medical License 1994 - 1997
American Board of Pediatrics Pediatric Rheumatology

Awards, Honors, & Recognition

Fellow (FACR) American College of Rheumatology

Clinical Trials

Triptorelin for Ovary Protection in Childhood Onset Lupus Start of enrollment: 2003 Jun 01
Completed
Phase 2
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus Start of enrollment: 2017 Aug 23
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

Achieving Medication-Free Remission in Patients With Juvenile Dermatomyositis.
Ilaria Maccora, Hermine I Brunner, Amy Cassedy, Mekibib Altaye, Megan Quinlan-Waters
ACR Open Rheumatology. 2024-12-20
25 Years of Biologics For The Treatment of Pediatric Rheumatic Diseases - Advances in Prognosis and Ongoing Challenges.
Michael Shishov, Pamela F Weiss, Deborah M Levy, Joyce C Chang, Sheila T Angeles-Han
Arthritis Care & Research. 2024-12-09
Clinical, Immunologic, and Genetic Characteristics in Patients with Syndrome of Undifferentiated Recurrent Fevers (SURF).
Marci Macaraeg, Elizabeth Baker, Elizabeth Handorf, Michael Matt, Elizabeth K Baker
Arthritis & Rheumatology. 2024-12-02

Journal Articles

Discovery of SERPINA3 as a Candidate Urinary Biomarker of Lupus Nephritis Activity
Michael Bennett, Hermine I Brunner, Prasad Devarajan, Gaurav Gulati, Jessica L Turnier, Sherry Thornton, David Witte, Bruce Aronow, Rheumatology
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016
Hermine I Brunner, Melissa L Mannion, Judyann C Olson, Vibeke Strand, Daniel J Lovell, Meredith P Riebschleger, Susan Shenoi, Journal of Rheumatology

Lectures

Tocilizumab Significantly Reduces Flares in Polyarticular Juvenile Idiopathic Arthritis
76th Annual Scienific Meeting, Washington, DC, USA
Tocilizumab Significantly Reduces Flares in Polyarticular Juvenile Idiopathic Arthritis
American College of Rheumatology, 76th Annual Scienific Meeting, Washington, DC, USA

Press Mentions

S100 Protein Levels Predict Abatacept Response in Juvenile Idiopathic ArthritisAugust 8th, 2024
Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic DiseasesNovember 3rd, 2021
Extensive Assessment Critical to Dispel 'Ambiguity' Mimics in Juvenile DermatomyositisAugust 6th, 2021
Join now to see all

Grant Support

Towards Measures Of Lupus Nephritis Activity &Damage For ChildrenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
Improved Diagnostics &Advanced Magnetic Resonance Imaging For Pediatric NpsleNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
Improved Diagnostics &Advanced Magnetic Resonance Imaging For Pediatric NpsleNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2009
Efficacy Measures For Pediatric Lupus StudiesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
Clinical Trial: Triptorelin For Ovary Protection In LupusNational Center For Research Resources2008
Atherosclerosis Prevention In Pediatric Lupus Erythematosus (APPLE)National Center For Research Resources2006–2007
Triptorelin For Ovary Protection In LupusNational Center For Research Resources2005–2007
Long-Term Outcomes In Systemic Lupus ErythematosusNational Center For Research Resources2005–2007
Triptorelin For Ovary Protection In Childhood LipusFood And Drug Administration2005–2007
Meaningful Outcome Measures For Pediatrc Lupus TrialsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2006
Guidelines For Steroids In Children With LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2005
Meaningful Outcome Measures For Pediatric Lupus TrialsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004
Gonadal Function In Childhood Onset SLENational Center For Research Resources2004